Skip to main content
. Author manuscript; available in PMC: 2009 Sep 30.
Published in final edited form as: Fitoterapia. 2007 Feb 3;78(3):250–252. doi: 10.1016/j.fitote.2006.12.001

Table 1.

Inhibition % of the E. elleryana extracts on M. tubercolosis and human T cells growtha

Plant extracts b Human T cells growth inhibition %c M. tubercolosis growth inhibition %d
50μg/ml 5μg/ml 50μg/ml 5μg/ml
B-H A I A I
B-E I I A I
B-M A I I I
L-H A I +/- I
L-E I I I I
L-M +/- I I I
S-H A I +/- I
S-E +/- I I I
S-M I I I I
a

Inhibition of growth: A (≥ 70%), +/− (<70% & ≥30%), I (< 30%)

b

Plant extracts: M (MeOH), E (EtOAc), H (hexane) obtained from: B (bark), L (leaves), S (stem).

c

DMSO control growth normalized to 100%.

d

Rifampicin (5 μg/ml) and isoniazid (50 μg/ml) yielded 99.0% and 96.7% inhibition, respectively.